Prenatal genetic evaluation of fetuses with structural anomaly: is it time to shift from microarray to exome sequencing as a first‐tier test?
Ultrasound in Obstetrics & Gynecology · 2023
DOI: 10.1002/uog.26120 ↗Kurz gefasst
Leserbrief in der Zeitschrift Ultrasound in Obstetrics & Gynecology, 2023. Verfasst von X-M Lin und 1 weiteren Autor:innen. Beteiligte Einrichtung: Prenatal Diagnostic Center, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, Guangdong, China. Hauptthemen laut MEDLINE: Prenatal Diagnosis, Fetus. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 14 Literaturangaben.
Abstract (Originalsprache)
Linked article: This Correspondence comments on Yaron et al. Click here to view the article.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Prenatal Diagnostic Center, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, Guangdong, China.
ORCID-Profile: D-Z Li
Zitieren
APA
Lin, X. M., & Li, D. Z. (2023). Prenatal genetic evaluation of fetuses with structural anomaly: is it time to shift from microarray to exome sequencing as a first‐tier test?. Ultrasound in Obstetrics & Gynecology. https://doi.org/10.1002/uog.26120
Vancouver
Lin XM, Li DZ. Prenatal genetic evaluation of fetuses with structural anomaly: is it time to shift from microarray to exome sequencing as a first‐tier test?. Ultrasound in Obstetrics & Gynecology. 2023. doi:10.1002/uog.26120
BibTeX
@article{Lin2023,
author = {Lin, X-M and Li, D-Z},
title = {Prenatal genetic evaluation of fetuses with structural anomaly: is it time to shift from microarray to exome sequencing as a first‐tier test?},
journal = {Ultrasound in Obstetrics & Gynecology},
year = {2023},
doi = {10.1002/uog.26120}
}
EUVIMED